Erythroid dysplasia and RS are significantly more frequent after haploidentical PBSCT, yet in the absence of SF3B1 mutations and without independent prognostic significance, they likely represent reactive marrow changes rather than clonal disease. Transplant modality and patient age remain key determinants of post-transplant outcome.
Hollenstein et al. (Wed,) studied this question.